The effects of peracetic acid-hydrogen peroxide reprocessing on dialyzer solute and water permeability

Pharmacotherapy

Volumn 19, Issue 9, 1999, Pages 1042-1049

  Scott, Meri K ^a   Mueller, Bruce A ^a   Sowinski, Kevin M ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CELLULOSE DERIVATIVE; CREATININE; DIALYSIS FLUID; HYDROGEN PEROXIDE; INULIN; MYOGLOBIN; PERACETIC ACID; POLYSULFONE; UREA; VANCOMYCIN;

AQUEOUS SOLUTION; ARTICLE; ARTIFICIAL KIDNEY; COMPARATIVE STUDY; HEMODIALYSIS; MEMBRANE TRANSPORT; METABOLIC CLEARANCE RATE; TRANSPORT KINETICS; ULTRAFILTRATION; VALIDATION PROCESS; WATER PERMEABILITY;

CREATININE; HEMODIALYSIS SOLUTIONS; HYDROGEN PEROXIDE; INULIN; MYOGLOBIN; PERACETIC ACID; PERMEABILITY; RANDOM ALLOCATION; RENAL DIALYSIS; SERUM ALBUMIN; TIME FACTORS; UREA; VANCOMYCIN; WATER;

EID: 0032831551     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.13.1042.31587     Document Type: Article

References (33)

1. Tokars JI, Alter MJ, Favero MS. National surveillance of dialysis-associated diseases in the United States. Washington, DC: U.S. Department of Health and Human Services, 1996.
2. Vlchek D. Costs of dialyzer reuse [abstr]. J Am Soc Nephrol 1994;5:429.
3. Daugirdas JT, Ing TS. First-use reactions during hemodialysis: a definition of subtypes. Kidney Int 1988;33:S37-43.
4. Kaufman AM, Godmere RO, Levin NW. Dialyzer reuse. In: Daugirdas JT, Ing TS, eds. Handbook of dialysis. Boston: Little, Brown, 1994:137-48.
5. Henderson LW, Cheung AK, Chenoweth DE. Choosing a membrane. Am J Kidney Dis 1983;3:5-20.
6. Rockel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D. Permeability and secondary membrane formation of a high-flux polysulfone filter. Kidney Int 1986;30:429-32.
7. 2-microglobulin and complement activation in hemodialysis patients. Am J Nephrol 1992;12:29-36.
8. 2-microglobulin removal in hemodiafiltration, Am J Kidney Dis 1992;19:433-8.
9. Leypoldt JK, Cheung AK, Deeter B. Effect of Renalin reprocessing on small and large solute clearances (K) by hemodialyzers (HD) [abstr]. J Am Soc Nephrol 1995;6:607.
10. Leypoldt JK, Cheung AK, Clark WR, et al. Characterization of low- and high-flux dialyzers with reuse in the Hemo study: interim report [abstr]. J Am Soc Nephrol 1996;7:1518.
11. Held PJ, Wolfe RA, Gaylin DS, Port FK, Levin NW, Turenne MN. Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 1994;23:692-708.
12. Feldman HI, Kinosian M, Bilker WB, et al. Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA 1996;276:620-5.
13. Goldman M, Lagmiche M, Dhaene M, Amraoui Z, Thayse C, Vanherweghem JL. Adsorption of beta 2-microglobulin on dialysis membranes: comparison of different dialyzers and effects of reuse procedures. Int J Artif Organs 1989;12:373-8.
14. Scott MK, Mueller BA, Sowinski KM, Clark WR. Dialyzer-dependent changes in solute and water permeability with bleach reprocessing. AmJ Kidney Dis 1999;33:87-96.
15. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994;46:830-7.
16. Kaplan AA, Halley SDE, Lapkin RA, Graeber CW. Dialysate protein loss with bleach processed polysulfone dialyzers. Kidney Int 1995;47:573-8.
17. Lowrie EG, Lew NL. Commonly measured laboratory variables in hemodialysis patients: relationships among them and to death risk. Semin Nephrol 1992;12:276-83.
18. Leypoldt JK, Cheung AK, Carroll C, et al. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis membrane survival. Am J Kidney Dis 1999;33:349-55.
19. Scott MK, Macias WL, Kraus MA, Clark WR, Carfagna MA, Mueller BA. Effects of dialysis membrane on intradialytic vancomycin administration. Pharmacotherapy 1997;17:256-62.
20. Scott MK, Mueller BA, Clark WR. Vancomycin mass transfer characteristics of high-flux cellulosic dialyzers. Nephrol Dial Transplant 1997;12:2647-53.
21. Kunas G, Burke RA, Brierton MA, Ofsthun NJ. The effect of blood contact and reuse on the transport properties of high-flux dialysis membranes. ASAIO J 1996;42:288-94.
22. Association for the Advancement of Medical Instrumentation. Reuse of hemodialyzers, 2nd ed. Arlington, VA: AAMI, 1993.
23. Follin SL, Mueller BA, Scott MK, Carfagna MA, Kraus MA. Falsely elevated serum vancomycin concentrations in hemodialysis patients. Am J Kidney Dis 1996;27:67-74.
24. Baxter Healthcare Corp. 5M1546 CT, cellulose triacetate hollow fiber dialyzer, model CT-190G, package insert. Deerfield, IL;1988.
25. Feldman HI, Ward RA. Dialyzer reuse: lingering doubt. Semin Dial 1998;11:276-8.
26. Murthy BV, Sundaram S, Jaber BL, Perrella C, Meyer KB, Pereira BJ. Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers. J Am Soc Nephrol 1998;9:464-72.
27. Sherman RA, Cody RP, Rogers ME, Solanchick JC. The effect of dialyzer reuse on dialysis delivery. Am J Kidney Dis 1994;24:924-6.
28. Fresenius USA, Inc. Hemoflow F80A, Fresenius polysulfone hollow fiber dialyzer, model F80A, package insert. Walnut Creek, CA;1995.
29. Fresenius USA, Inc. Hemoflow F80B, Fresenius polysulfone hollow fiber dialyzer, model F80B, package insert. Walnut Creek, CA;1995.
30. 2-microglobulin. J Am Soc Nephrol 1999;10:117-27.
31. Deppisch R, Ritz E, Ahnsch G, Schols M, Rautgerberg E. Renal filtration and catabolism of complement protein D. N Engl J Med 1985;312:395-9.
32. Pascual M, Steiger G, Estreicher J, Macon K, Volankis JE, Schifferli JA. Metabolism of complement factor D in renal failure. Kidney Int 1988;34:529-36.
33. Kaiser J, Opperman M, Gotze O, et al. Significant reduction of factor D and immunosuppressive complement fragment Ba by haemofiltration. Blood Purif 1995;13:314-21.